S1PR1 and multiple sclerosis: Siponimod is a dual sphingosine-1-phosphate receptor 1 (S1P1) and 5 (S1P5) selective modulator, developed for the oral treatment of multiple sclerosis (Kappos et al. 2016, 2018; Pan et al. 2013).